Kerri Beckmann

APrf Kerri Beckmann

Senior Research Fellow

School of Public Health

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


Dr Kerri Beckmann is a cancer epidemiologist with an interest in the early detection and treatment of breast, prostate and colorectal cancer. She  completed her PhD at the University of Adelaide, Australia in 2014. She is employed at the University of South Australia as a Senior Research Fellow in the Cancer Epidemiology and Population Health Research Unit. 
Kerri was a recipient of a NHMRC Sydney Sax Early Career Fellowship and undertook her post-doctoral research as a Visiting Research Fellow at Kings College London working with the Translational Oncology and Urology Research Team. 
Much of her current work focuses on prostate cancer outcomes research. She has had a longstanding association with the South Australian Prostate Cancer Clinical Outcomes Collaborative and is involved in analysis of trends in clinical characteristics, treatment patterns and health outcomes using data from this clinical registry. She is also involved in other research projects the focus on patterns of care and outcomes for people affected by colorectal cancer and breast cancer.
Kerri currently holds a Cancer Council SA Beat Cancer Mid-Career Fellowship to investigate adverse outcomes of cancers treatments.

Kerri's main research area relates to determining which treatments for prostate cancer are the most effective, that is which lead to the best survival outcomes and least harm due to treatment side effects. Other areas of research interest include:1) patterns of care and outcomes in relation to breast and colorectal cancer; 2) sociodemographic disparities in presentation, treatment and outcomes; 3) evaluation of cancer screening programs; and 4) analytical methods for comparative effectiveness in assessing treatment options.

Currently, Kerri leads the SA arm of a multi-jurisdictional data-linkage project to demonstrate the value of linking clinical data with state and national administrative datasets for long-term follow-up of treatment, outcomes and adverse effects. She is also leading a state-wide project to develop a Prostate Cancer Outcomes Report Card to inform men of likely clinical and functional outcomes following various treatments.

Year Citation
2025 Tiruye, T., Jay, A., Higgs, B., O'Callaghan, M., FitzGerald, L., Moretti, K., . . . Beckmann, K. (2025). Urinary and colorectal procedures following prostate cancer treatment. BJU International, 135(S2), 98.
2025 Tiruye, T., Duko, B., Mekonnen, L., Ward, P., Nguyen, T. H. H. D., Byrne, S., . . . Beckmann, K. (2025). Cancer Burden Attributable to Potentially Modifiable Risk Factors in Australia. Cancers, 17(19), 1-30.
DOI Scopus1 WoS1
2025 Dars, S., Tiruye, T., Roder, D., Banwell, H. A., Olver, I., & Beckmann, K. (2025). Patterns and factors associated with podiatry service use among colorectal cancer patients following chemotherapy in South Australia: focus on Chemotherapy-Induced Peripheral Neuropathy (CIPN). Journal of Multidisciplinary Healthcare, 18, 6361-6372.
DOI
2025 Beckmann, K., Kearney, B. J., Shanmuganathan, N., Yeung, D., & Hughes, T. (2025). Disease-specific survival for people with chronic myeloid leukaemia, South Australia, 1980–2020: a retrospective cohort study. Medical Journal of Australia, 223(11), 3 pages.
DOI
2025 Irenaeus, S., Garmo, H., Gedeborg, R., Ahlberg, M., Robinson, D., Stattin, P., & Beckmann, K. (2025). Potential gains from radical treatment of men with prostate cancer according to life expectancy. Bjui Compass, 6(9), 9 pages.
DOI
2025 Lin, E., Garmo, H., Beckmann, K., Bratt, O., Akre, O., Stattin, P., & Gedeborg, R. (2025). Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons. International Journal of Cancer, online, 7 pages.
DOI Scopus1 WoS1 Europe PMC1
2025 Lin, E., Garmo, H., Beckmann, K., Bratt, O., Stattin, P., & Gedeborg, R. (2025). Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden. Cancer Epidemiology Biomarkers and Prevention, 34(9), 1585-1592.
DOI
2025 Jayasinghe, D., Pham, V. V. H., Beckmann, K., Benyamin, B., & Lee, S. H. (2025). Analyzing complex traits and diseases using GxE PRS: genotype-environment interaction in polygenic risk score models. Journal of Human Genetics, 70(11), 547-556.
DOI
2025 Monroy-Iglesias, M. J., Thavarajah, R., Beckmann, K., Josephs, D. H., Irshad, S., Karagiannis, S. N., . . . Santaolalla, A. (2025). Effects of vitamin D on COVID-19 risk and hospitalisation in the UK biobank. Plos One, 20(7 July), 14 pages.
DOI Europe PMC1
2025 Charlick, M., Murphy, M., Murphy, B., Ettridge, K., O'Callaghan, M., Sara, S., . . . Beckmann, K. (2025). Sexual wellbeing support for men with prostate cancer: a qualitative study with patients. Translational Andrology and Urology, 14(4), 913-927.
DOI Scopus1 WoS1 Europe PMC1
2025 Ng, H. S., Johansen, C., Li, M., Roder, D., Beckmann, K., & Koczwara, B. (2025). Patterns of medication use following breast cancer diagnosis: an Australian population-based study. SUPPORTIVE CARE IN CANCER, 33(8), 11 pages.
DOI
2025 Tiruye, T., Jay, A., O'Callaghan, M., FitzGerald, L. M., Roder, D., & Beckmann, K. (2025). Post‑prostatectomy rehospitalisation rates and risk factors in South Australian men with prostate cancer: evidence from linked data. International Urology and Nephrology, online, 1-10.
DOI
2025 Tiruye, T., Higgs, B., O'Callaghan, M., FitzGerald, L. M., Roder, D., & Beckmann, K. (2025). Socioeconomic and Geographic Disparities in Anorectal and Urinary Procedures Following Radiotherapy for Prostate Cancer. Cancer Medicine, 14(15, article no. e71135), 1-10.
DOI Europe PMC1
2025 Bott, R., Zylstra, J., Knight, W., Whyte, G. P., Lane, A. M., Moss, C., . . . Pate, J. (2025). Prehabilitation of Patients With Oesophageal Malignancy Undergoing Peri-Operative Treatment (Pre-EMPT): Outcomes From a Prospective Controlled Trial. Journal of Surgical Oncology, 131(8), 1508-1520.
DOI Scopus3 WoS2 Europe PMC3
2025 Charlick, M., Ettridge, K., Tiruye, T., O'Callaghan, M., Sara, S., Jay, A., & Beckmann, K. (2025). Improving sexual well-being support for men with prostate cancer: the health professional perspective. European Journal of Cancer Care, 2025(1, article no. 2875201), 1-11.
DOI
2025 Charlick, M., Tiruye, T., Ettridge, K., O'Callaghan, M., Jay, A., & Beckmann, K. (2025). Use of erectile dysfunction treatments after prostate cancer treatment and their perceived impact on men's sex life: an analysis of patient reported outcome survey data. BMC Urology, 25(21), 1-11.
DOI Scopus1 WoS1 Europe PMC2
2025 Tiruye, T., Jay, A., Higgs, B., O'Callaghan, M., FitzGerald, L. M., Moretti, K., . . . Beckmann, K. (2025). Comparing post‑treatment urinary and colorectal procedures in prostate cancer patients using population‑based linked data. International Urology and Nephrology, 57(4), 1189-1198.
DOI Scopus2 WoS2 Europe PMC2
2025 Ng, H. S., Johansen, C., Li, M., Roder, D., Beckmann, K., & Koczwara, B. (2025). Patterns of medication use following breast cancer diagnosis: an Australian population-based study.. Supportive Care in Cancer, 33(8, article no. 668), 1-11.
DOI
2024 Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Moretti, K., & Beckmann, K. (2024). Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer. Cancer Epidemiology, 88(102516), 1-7.
DOI Scopus7 WoS7 Europe PMC5
2024 Tiruye, T., O'Callaghan, M., FitgGerald, L. M., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2024). Medication-based comorbidity measures and prostate cancer treatment selection. Clinical Genitourinary Cancer, 22(2), 599-609.
DOI Scopus8 WoS8 Europe PMC6
2024 Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Moretti, K., Caughey, G. E., & Beckmann, K. (2024). Impact of comorbidities on prostate cancer‐specific mortality: A population‐based cohort study. The Prostate, 84(12), 1138-1145.
DOI Scopus10 WoS9 Europe PMC9
2024 Tiruye, T., Hiwase, M., Charlick, M., O'Callaghan, M., Khalid, A., Li, M., . . . Beckmann, K. (2024). Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer. Psychooncology, 33(7), e6369-1-e6369-11.
DOI Scopus1 WoS2
2024 Ong, W. L., Krishnaprasad, K., Bensley, J., Steeper, M., Beckmann, K., Breen, S., . . . Millar, J. (2024). Population-based prostate cancer outcomes registries - what have we learned and where are we heading?. BJU International, 134(S2), 9-11.
DOI Scopus5 WoS5 Europe PMC4
2024 Charlick, M., Tiruye, T., Ettridge, K., O'Callaghan, M., Sara, S., Jay, A., & Beckmann, K. (2024). Prostate cancer related sexual dysfunction and barriers to help seeking: a scoping review. Psycho-oncology, 33(8), 1-13.
DOI Scopus6 WoS6 Europe PMC6
2024 Jayasinghe, D., Eshetie, S., Beckmann, K., Benyamin, B., & Lee, S. H. (2024). Advancements and limitations in polygenic risk score methods for genomic prediction: a scoping review. Human Genetics, 143(12), 1401-1431.
DOI Scopus10 WoS11 Europe PMC16
2024 Tiruye, T., & Beckmann, K. (2024). Communicating prostate cancer outcomes data to consumers– A brief communication. Urologic Oncology Seminars and Original Investigations, 42(10), 331-331.e11.
DOI Scopus2 WoS1 Europe PMC1
2024 Jayasinghe, D., Momin, M. M., Beckmann, K., Hyppönen, E., Benyamin, B., & Lee, S. H. (2024). Mitigating type 1 error inflation and power loss in GxE PRS: Genotype–environment interaction in polygenic risk score models. Genetic Epidemiology, 48(2), 85-100.
DOI Scopus6 WoS7 Europe PMC8
2024 Tiruye, T. Y., O'Callaghan, M., Ettridge, K., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2024). Clinical and functional outcomes for risk-appropriate treatments for prostate cancer. BJUI Compass, 5(1), 109-120.
DOI Scopus10 WoS10 Europe PMC7
2023 Tiruye, T., Ettridge, K., O'Callaghan, M., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2023). Reporting real-world data on prostate cancer treatment outcomes to consumers: the prostate cancer report card. European Journal of Cancer Care, 2023(6660371), 1-12.
DOI Scopus6 WoS6
2023 Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Morreti, K., & Beckmann, K. (2023). Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer. Cancer Epidemiology, 87(102482), 1-6.
DOI Scopus6 WoS5 Europe PMC1
2023 Tiruye, T., David, R., O'Callaghan, M., FitzGerald, L. M., Higgs, B., Kahokehr, A. A., . . . Beckmann, K. (2023). Risk of secondary malignancy following radiation therapy for prostate cancer. Scientific Reports, 23(20083), 1-10.
DOI Scopus15 WoS15 Europe PMC12
2023 Tiruye, T., O'Callaghan, M., Ettridge, K., Jay, A., Santoro, K., Moretti, K., & Beckmann, K. (2023). Factors impacting on sexual function among men on active surveillance for prostate cancer. The Prostate, 83(7), 678-687.
DOI Scopus10 WoS8 Europe PMC7
2023 Dars, S., Buckley, E., Beckmann, K., Roder, D., & Banwell, H. (2023). Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists. Journal of Foot and Ankle Research, 16(1), 1-14.
DOI Scopus2 WoS2 Europe PMC1
2023 Beckmann, K. R., O'Callaghan, M. E., Vincent, A. D., Moretti, K. L., & Brook, N. R. (2023). Clinical outcomes for men with positive surgical margins after radical prostatectomy—results from the South Australian Prostate Cancer Clinical Outcomes Collaborative community-based registry. Asian Journal of Urology, 10(4), 502-511.
DOI Scopus5 WoS5 Europe PMC7
2023 Beckmann, K., Cahill, D., Brown, C., Van Hemelrijck, M., & Kinsella, N. (2023). Developing a consensus statement for psychosocial support in active surveillance for prostate cancer. Bjui Compass, 4(1), 104-113.
DOI Scopus3 WoS2 Europe PMC4
2023 Westerberg, M., Beckmann, K., Gedeborg, R., Irenaeus, S., Holmberg, L., Garmo, H., & Stattin, P. (2023). Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence. Journal of Clinical Epidemiology, 155, 22-30.
DOI Scopus3 WoS3 Europe PMC3
2023 Beckmann, K., Santaolalla, A., Sugimoto, M., Carroll, P., Rubio, J., Villers, A., . . . Elhage, O. (2023). Risk of progression following a negative biopsy in prostate cancer active surveillance. Prostate Cancer and Prostatic Diseases, 26(2), 403-409.
DOI Scopus4 WoS4 Europe PMC4
2022 Monroy-Iglesias, M. J., Crescioli, S., Beckmann, K., Le, N., Karagiannis, S. N., Van Hemelrijck, M., & Santaolalla, A. (2022). Antibodies as biomarkers for cancer risk: A systematic review. Clinical and Experimental Immunology, 209(1), 46-63.
DOI Scopus22 WoS19 Europe PMC19
2022 Beckmann, K. R., Bangma, C. H., Helleman, J., Bjartell, A., Carroll, P. R., Morgan, T., . . . Roobol, M. J. (2022). Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database. Prostate, 82(7), 876-879.
DOI Scopus2 WoS2 Europe PMC4
2022 Beckmann, K., Crawley, D., Nelson, W. G., Platz, E. A., Selvin, E., Van Hemelrijck, M., & Rohrmann, S. (2022). Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer. Cancer Causes and Control, 33(3), 429-440.
DOI Scopus4 WoS5 Europe PMC4
2022 Shah, S., Beckmann, K., Van Hemelrijck, M., Challacombe, B., Popert, R., Dasgupta, P., . . . Santaolalla, A. (2022). Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database (BMC Cancer, (2021), 21, 1, (573), 10.1186/s12885-021-08255-z). BMC Cancer, 22(1), 1 page.
DOI
2022 Zylstra, J., Whyte, G. P., Beckmann, K., Pate, J., Santaolalla, A., Gervais-Andre, L., . . . Davies, A. (2022). Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial. British Journal of Sports Medicine, 56(7), 402-409.
DOI Scopus55 WoS57 Europe PMC47
2022 Bundred, J. R., Michael, S., Stuart, B., Cutress, R. I., Beckmann, K., Holleczek, B., . . . Bundred, N. J. (2022). Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis. BMJ, 378(e070346), 11 pages.
DOI Scopus92 WoS87 Europe PMC73
2022 Tiruye, T., O’Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., . . . Beckmann, K. (2022). Patient-reported functional outcome measures and treatment choice for prostate cancer. BMC Urology, 22(1), 1-11.
DOI Scopus13 WoS13 Europe PMC12
2022 Radbone, C., Beckmann, K., Roder, D., O'Callaghan, M., Moretti, K., Fitzgerald, L., & Buckley, L. (2022). Multi-jurisdictional Prostate cancer registry linkage. International Journal of Population Data Science, 7(3, article no. 2101), 1.
DOI
2022 Beckmann, K., Kearney, B. J., Yeung, D., Hiwase, D., Li, M., & Roder, D. M. (2022). Changes in five-year survival for people with acute leukaemia in South Australia, 1980-2016. Medical Journal of Australia, 216(6), 296-302.
DOI Scopus9 WoS9 Europe PMC9
2021 Beckmann, K., Selva-Nayagam, S., Olver, I., Miller, C., Buckley, E. S., Powell, K., . . . Oehler, M. K. (2021). Carcinosarcomas of the uterus: prognostic factors and impact of adjuvant treatment. Cancer Management and Research, 13, 4633-4645.
DOI Scopus7 WoS7 Europe PMC5
2021 Beckmann, K., Santaolalla, A., Helleman, J., Carroll, P., Ha Chung, B., Shiong Lee, L., . . . Elhage, O. (2021). Comparison of characteristics, follow-up and outcomes of active surveillance for prostate cancer according to ethnicity in the GAP3 Global Consortium Database. European Urology Open Science, 34, 47-54.
DOI Scopus2 WoS4 Europe PMC4
2021 Tomer, A., Nieboer, D., Roobol, M. J., Bjartell, A., Steyerberg, E. W., Rizopoulos, D., . . . Helleman, J. (2021). Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance. BJU International, 127(1), 96-107.
DOI Scopus21 Europe PMC23
2021 Singh, S., Sandhu, P., Beckmann, K., Santaolalla, A., Dewan, K., Clovis, S., . . . Elhage, O. (2021). Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment. BJU International, 128(1), 72-78.
DOI Scopus6 WoS6 Europe PMC3
2021 Bott, R. K., Beckmann, K., Zylstra, J., Wilkinson, M. J., Knight, W. R. C., Baker, C. R., . . . Davies, A. R. (2021). Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins. Acta Oncologica, 60(5), 672-680.
DOI Scopus4 WoS5 Europe PMC5
2021 Monroy‐iglesias, M. J., Moss, C., Beckmann, K., Hammar, N., Walldius, G., Bosco, C., . . . Santaolalla, A. (2021). Serum total bilirubin and risk of cancer: A swedish cohort study and meta‐analysis. Cancers, 13(21), 13 pages.
DOI Scopus20 WoS16 Europe PMC21
2021 Beckmann, K., Cahill, D., Brown, C., van Hemelrijck, M., & Kinsella, N. (2021). Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer. Translational Andrology and Urology, 10(6), 2728-2736.
DOI Scopus14 WoS14 Europe PMC14
2021 Shah, S., Beckmann, K., Van Hemelrijck, M., Challacombe, B., Popert, R., Dasgupta, P., . . . Santaolalla, A. (2021). Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database. BMC Cancer, 21(1), 12 pages.
DOI Scopus3 WoS2 Europe PMC1
2021 Beckmann, K., Garmo, H., Lissbrant, I. F., & Stattin, P. (2021). The value of real-world data in understanding prostate cancer risk and improving clinical care: Examples from Swedish registries. Cancers, 13(4), 1-19.
DOI Scopus13 WoS10 Europe PMC12
2021 Kum, F., Beckmann, K., Aya, H., Singh, S., Sandhu, P., Sra, S., . . . Elhage, O. (2021). Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre. Prostate Cancer and Prostatic Diseases, 24(2), 549-557.
DOI Scopus3 WoS3 Europe PMC2
2021 Monroy-Iglesias, M. J., Russell, B., Crawley, D., Allen, N. E., Travis, R. C., Perez-Cornago, A., . . . Beckmann, K. (2021). Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank. International Journal of Cancer, 148(4), 825-834.
DOI Scopus33 WoS34 Europe PMC33
2020 Beckmann, K., Garmo, H., Nilsson, P., Franck Lissbrant, I., Widmark, A., & Stattin, P. (2020). Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998–2016. Acta Oncologica, 59(5), 549-557.
DOI Scopus13 WoS13 Europe PMC10
2020 Beckmann, K., Garmo, H., Lindahl, B., Holmberg, L., Stattin, P., Adolfsson, J., . . . Van Hemelrijck, M. (2020). Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study. Prostate Cancer and Prostatic Diseases, 23(3), 527-533.
DOI Scopus15 WoS16 Europe PMC16
2020 Santaolalla, A., Beckmann, K., Kibaru, J., Josephs, D., Van Hemelrijck, M., & Irshad, S. (2020). Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic. Frontiers in Physiology, 11(564387), 18 pages.
DOI Scopus30 WoS27 Europe PMC24
2020 Parker, J., Crawley, D., Garmo, H., Lindahl, B., Styrke, J., Adolfsson, J., . . . Beckmann, K. (2020). Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study. Frontiers in Oncology, 10(571838), 8 pages.
DOI Scopus4 WoS4 Europe PMC4
2020 Bott, R. K., Beckmann, K., Zylstra, J., Wilkinson, M. J., Knight, W. R. C., Baker, C. R., . . . Zeki, S. S. (2020). Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin. British Journal of Surgery, 107(13), 1801-1810.
DOI Scopus9 WoS10 Europe PMC7
2020 Burdett, N., Hsu, K., Xiong, L., Tapia-Rico, G., Beckmann, K., Karapetis, C., & Brown, M. P. (2020). Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapy. Asia-Pacific Journal of Clinical Oncology, 16(2), 139-145.
DOI Scopus13 WoS12 Europe PMC10
2020 Morias, S., Buckley, E., Beckmann, K., O'Callaghan, M., Borg, M., & Short, M. (2020). Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005–2015. Radiotherapy and Oncology, 145, 138-145.
DOI Scopus3 WoS3 Europe PMC2
2019 Beckmann, K., O'Callaghan, M., Vincent, A., Cohen, P., Borg, M., Roder, D., . . . Moretti, K. (2019). Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings.. Asian journal of urology, 6(4), 321-329.
DOI Scopus10 WoS10 Europe PMC10
2019 Van Hemelrijck, M., Ji, X., Kattan, M. W., Helleman, J., Roobol, M. J., Nieboer, D., . . . Bruinsma, S. (2019). Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium. European Urology, 75(3), 523-531.
DOI Scopus73 WoS81 Europe PMC68
2019 Drost, F. J. H., Nieboer, D., Morgan, T. M., Carroll, P. R., Roobol, M. J., Trock, B., . . . Helleman, J. (2019). Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts. European Urology, 76(5), 693-702.
DOI Scopus23 WoS22 Europe PMC20
2019 Beckmann, K., Crawley, D., Nordström, T., Aly, M., Olsson, H., Lantz, A., . . . Van Hemelrijck, M. (2019). Association between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results. JAMA Network Open, 2(11), 12 pages.
DOI Scopus17 WoS19 Europe PMC20
2019 Ahlberg, M. S., Adami, H. O., Beckmann, K., Bertilsson, H., Bratt, O., Cahill, D., . . . Bill-Axelson, A. (2019). PCASTt/SPCG-17-A randomised trial of active surveillance in prostate cancer: Rationale and design. BMJ Open, 9(8), 7 pages.
DOI Scopus20 WoS23 Europe PMC16
2019 Beckmann, K., Kinsella, N., Olsson, H., Wallerstedt Lantz, A., Nordstrom, T., Aly, M., . . . Van Hemelrijck, M. (2019). Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?. BMC Urology, 19(1), 8 pages.
DOI Scopus1 Europe PMC1
2019 Kinsella, N., Beckmann, K., Cahill, D., Elhage, O., Popert, R., Cathcart, P., . . . Van Hemelrijck, M. (2019). A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Years After Diagnosis of Prostate Cancer. European Urology Oncology, 2(4), 464-470.
DOI Scopus9 WoS8 Europe PMC9
2019 Beckmann, K., Russell, B., Josephs, D., Garmo, H., Haggstrom, C., Holmberg, L., . . . Adolfsson, J. (2019). Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: A population-based case-control study. BMC Cancer, 19(1), 9 pages.
DOI Scopus13 WoS13 Europe PMC12
2019 Wu, W. Y. Y., Tabar, L., Tot, T., Fann, C. Y., Yen, A. M. F., Chen, S. L. S., . . . Chen, H. H. (2019). Imaging Biomarkers as Predictors for Breast Cancer Death. Journal of Oncology, 2019(2087983), 12 pages.
DOI Scopus13 WoS13 Europe PMC9
2019 Beckmann, K., Garmo, H., Adolfsson, J., Bosco, C., Johansson, E., Robinson, D., . . . Van Hemelrijck, M. (2019). Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer. European Urology, 75(4), 676-683.
DOI Scopus13 WoS12 Europe PMC10
2019 Tabár, L., Dean, P. B., Chen, T. H. H., Yen, A. M. F., Chen, S. L. S., Fann, J. C. Y., . . . Duffy, S. W. (2019). The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer, 125(4), 515-523.
DOI Scopus204 WoS183 Europe PMC142
2018 Russell, B., Garmo, H., Beckmann, K., Stattin, P., Adolfsson, J., & Van Hemelrijck, M. (2018). A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0. Plos One, 13(4), 10 pages.
DOI Scopus7 WoS6 Europe PMC7
2018 Hsieh, A. H. C., Tahkar, H., Koczwara, B., Kichenadasse, G., Beckmann, K., Karapetis, C., & Sukumaran, S. (2018). Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer. Asia Pacific Journal of Clinical Oncology, 14(2), e64-e70.
DOI Scopus12 WoS13 Europe PMC14
2018 Tabar, L., Chen, T. H. H., Yen, A. M. F., Chen, S. L. S., Fann, J. C. Y., Chiu, S. Y. H., . . . Duffy, S. W. (2018). Effect of mammography screening on mortality by histological grade. Cancer Epidemiology Biomarkers and Prevention, 27(2), 154-157.
DOI Scopus34 WoS30 Europe PMC28
2018 Beckmann, K., O'Callaghan, M., Vincent, A., Roder, D., Millar, J., Evans, S., . . . Moretti, K. (2018). Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy. ANZ Journal of Surgery, 88(3), E183-E188.
DOI Scopus2 WoS2 Europe PMC2
2018 Lu, T. C., Moretti, K., Beckmann, K., Cohen, P., & O Callaghan, M. (2018). ISUP Group 4 – a Homogenous Group of Prostate Cancers?. Pathology and Oncology Research, 24(4), 921-925.
DOI Scopus11 WoS11 Europe PMC8
2017 Campbell, J., O'Callaghan, M., Raymond, E., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(6), 629-634.
DOI Scopus7 WoS5 Europe PMC6
2017 O'Callaghan, M., Raymond, E., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: A systematic review of prognostic accuracy and validity. Prostate Cancer and Prostatic Diseases, 20(4), 378-388.
DOI Scopus21 WoS18 Europe PMC18
2017 Campbell, J., Raymond, E., O'Callaghan, M., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(5), e827-e834.
DOI Scopus23 WoS22 Europe PMC19
2017 Beckmann, K., Vincent, A., O'Callaghan, M., Cohen, P., Chang, S., Borg, M., . . . Moretti, K. (2017). Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings. BMC cancer, 17(1), 537.
DOI Scopus3 WoS3 Europe PMC2
2017 Roder, D., Farshid, G., Kollias, J., Koczwara, B., Karapetis, C., Adams, J., . . . Price, T. (2017). Female breast cancer management and survival: the experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly. Journal of Evaluation in Clinical Practice, 23(6), 1433-1443.
DOI Scopus6 WoS7 Europe PMC5
2017 Roder, D., Farshid, G., Gill, G., Kollias, J., Koczwara, B., Karapetis, C., . . . Beckmann, K. (2017). Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation. Journal of Evaluation in Clinical Practice, 23(3), 508-516.
DOI Scopus4 WoS2 Europe PMC2
2017 Buckley, E., Farshid, G., Gill, G., Kollias, J., Koczwara, B., Karapetis, C., . . . Roder, D. (2017). Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model. European Journal of Cancer Care, 26(4), e12673-1-e12673-8.
DOI
2017 Raymond, E., O'Callaghan, M., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review. Radiation Oncology, 12(1), 56-1-56-20.
DOI Scopus15 WoS15 Europe PMC10
2017 Beckmann, K., Moore, J., Wattchow, D., Young, G., & Roder, D. (2017). Short-term outcomes after surgical resection for colorectal cancer in South Australia. Journal of evaluation in clinical practice, 23(2), 316-324.
DOI Scopus16 WoS16 Europe PMC12
2017 Beckmann, K., O'Callaghan, M., Ruseckaite, R., Kinnear, N., Miller, C., Evans, S., . . . Moretti, K. (2017). Prostate cancer outcomes for men who present with symptoms at diagnosis. BJU International, 119(6), 862-871.
DOI Scopus6 WoS6 Europe PMC5
2017 O'Callaghan, M. E., Raymond, E., Campbell, J. M., Vincent, A. D., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity. International Journal of Radiation Oncology Biology Physics, 98(2), 318-337.
DOI Scopus11 WoS10 Europe PMC8
2017 Campbell, J., Raymond, E., O'Callaghan, M., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. Journal of Urology, 197(4), 900.
DOI WoS1
2017 Tabar, L., Chen, T. H. H., Hsu, C. Y., Wu, W. Y. Y., Yen, A. M. F., Chen, S. L. S., . . . Duffy, S. W. (2017). Evaluation issues in the swedish two-county trial of breast cancer screening: An historical review. Journal of Medical Screening, 24(1), 27-33.
DOI Scopus12 WoS5 Europe PMC6
2016 Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Millar, J., & Evans, S. (2016). A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease. BMC Cancer, 16(1), 11 pages.
DOI Scopus24 WoS25 Europe PMC20
2016 Beckmann, K. R., Bennett, A., Young, G. P., Cole, S. R., Joshi, R., Adams, J., . . . Roder, D. (2016). Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study. BMC Health Services Research, 16(1), 1-14.
DOI Scopus54 WoS50 Europe PMC42
2016 Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Zalcberg, J., . . . Evans, S. (2016). Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset. BMC Research Notes, 9(1), 37.
DOI Scopus5 Europe PMC4
2015 Beckmann, K., Lynch, J., Hiller, J., Farshid, G., Duffy, S., & Roder, D. (2015). Estimating over-diagnosis of breast cancer (Authors' Reply). International Journal of Cancer, 136(10), 2487.
DOI Scopus1 WoS1 Europe PMC1
2015 Beckmann, K., Lynch, J., Hiller, J., Farshid, G., Houssami, N., Duffy, S., & Roder, D. (2015). A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. International Journal of Cancer, 136(6), 1411-1421.
DOI Scopus30 WoS26 Europe PMC18
2015 Beckmann, K., Duffy, S., Lynch, J., Hiller, J., Farshid, G., & Roder, D. (2015). Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects. Journal of medical screening, 22(3), 127-135.
DOI Scopus27 WoS26 Europe PMC21
2014 Beckmann, K., Roder, D., Hiller, J., Farshid, G., & Lynch, J. (2014). Influence of mammographic screening on breast cancer incidence trends in South Australia. Asian Pacific Journal of Cancer Prevention (APJCP), 15(7), 3105-3112.
DOI Scopus8 WoS3 Europe PMC6
2014 Beckmann, K., Bennett, A., Young, G., & Roder, D. (2014). Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage. Journal of Evaluation in Clinical Practice, 20(4), 467-477.
DOI Scopus32 WoS30 Europe PMC30
2013 Beckmann, K., Roder, D., Hiller, J., Farshid, G., & Lynch, J. (2013). Do breast cancer risk factors differ among those who do and do not undertake mammography screening?. Journal of Medical Screening, 20(4), 208-219.
DOI Scopus16 WoS16 Europe PMC14
2013 Behm, E., Beckmann, K., Dahlstrom, J., Zhang, Y., Cho, C., Stuart-Harris, R., . . . Buckingham, J. (2013). Surgical margins and risk of locoregional recurrence in invasive breast cancer: An analysis of 10-year data from the Breast Cancer Treatment Quality Assurance Project. The Breast, 22(5), 839-844.
DOI Scopus34 WoS32 Europe PMC22
2013 Beckmann, K., Farshid, G., Roder, D., Hiller, J., & Lynch, J. (2013). Impact of hormone replacement therapy use on mammographic screening outcomes. Cancer Causes & Control, 24(7), 1417-1426.
DOI Scopus7 WoS7 Europe PMC6
2012 Dobbinson, S., Wakefield, M., Hill, D., Girgis, A., Aitken, J. F., Beckmann, K., . . . Bowles, K. A. (2012). Children's sun exposure and sun protection: Prevalence in Australia and related parental factors. Journal of the American Academy of Dermatology, 66(6), 938-947.
DOI Scopus40 WoS32 Europe PMC25
2011 Beckmann, K. R., Buckingham, J., Craft, P., Dahlstrom, J. E., Zhang, Y., Roder, D., & Stuart Harris, R. (2011). Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. The breast, 20(2), 158-164.
DOI Scopus59 WoS56 Europe PMC45
2010 Craft, P., Buckingham, J., Dahlstrom, J., Beckmann, K., Zhang, Y., Stuart-Harris, R., . . . Tait, N. (2010). Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services. The Breast, 19(5), 396-401.
DOI Scopus41 WoS39 Europe PMC35
2009 Beckmann, K., Pinnock, C., Tamblyn, D., Kopsaftis, T., Stapleton, A., & Roder, D. (2009). Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort. Asia Pacific Journal of Clinical Oncology, 2009(5), 247-256.
DOI Scopus12 WoS11
2009 Beckmann, K., Olver, I., Young, G., Roder, D., Foreman, L., & Wilson, B. (2009). Patient and carer perceptions of cancer care in South Australia. Australian Health Review, 33(4), 645-655.
DOI Scopus3 WoS2 Europe PMC1
2008 Luke, C., Koczwara, B., Karapetis, C., Pittman, K., Price, T., Kotasek, D., . . . Roder, D. (2008). Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Australian and New Zealand Journal of Public Health, 32(4), 383-389.
DOI Scopus30 WoS31 Europe PMC26
2008 Roder, D., Houssami, N., Farshid, G., Gill, P., Luke, C., Downey, P., . . . Williamson, L. (2008). Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mamography screening in Australia. Breast Cancer Research and Treatment, Online(3), 1-2.
DOI Scopus114 WoS105 Europe PMC75
2008 Shahid, S., Beckmann, K. R., & Thompson, S. (2008). Supporting cancer control for indigenous Australians: Initiatives and challenges for cancer councils. Australian health review, 32(1), 56-65.
DOI Scopus14 WoS15 Europe PMC13
2008 Dobbinson, S., Wakefield, M., Hill, D., Girgis, A., Aitken, J. F., Beckmann, K., . . . Bowles, K. A. (2008). Prevalence and determinants of Australian adolescents' and adults' weekend sun protection and sunburn, summer 2003-2004. Journal of the American Academy of Dermatology, 59(4), 602-614.
DOI Scopus125 WoS112 Europe PMC87
2008 Jones, S., Rayner, J., & Beckmann, K. (2008). Solaria compliance with the Australia/New Zealand Standard in Adelaide. Health Promotion Journal of Australia, 19(3), 222-225.
DOI Scopus2 WoS2 Europe PMC1
2008 Jones, S. B. W., Beckmann, K., & Rayner, J. (2008). Australian primary schools' sun protection policy and practice: Evaluating the impact of the National Sunsmart Schools Program. Health Promotion Journal of Australia, 19(2), 86-90.
DOI Scopus57 WoS56 Europe PMC38
2007 Scully, M., Dixon, H., White, V., & Beckmann, K. (2007). Dietary, physical activity and sedentary behaviour among Australian secondary students in 2005. Health Promotion International, 22(3), 236-245.
DOI Scopus70 WoS68 Europe PMC51
2007 Abell, L., Beckmann, K., Strange, C., Leone, L., Kerrins, E., Lee, S., . . . Abram, L. (2007). Providing accommodation services for rural cancer patients: The experience in South Australia. Cancer Forum, 31(2), 98-104.
Scopus1 WoS1
2007 Beckmann, K., Strassnick, K., Abell, L., Hermann, J., & Oakley, B. (2007). Is a Chronic Disease Self-Management Program beneficial to people affected by cancer?. Australian Journal of Primary Health, 13(1), 36-44.
DOI Scopus12 WoS9
2003 Beckmann, K., Iosifidis, P., Shorne, L., Gilchrist, S., & Roder, D. (2003). Effects of variations in hysterectomy status on population coverage by cervical screening. Australian and New Zealand Journal of Public Health, 27(5), 507-512.
DOI Scopus8 WoS6 Europe PMC5
2001 Beckmann, K. R., Kirke, B. A., McCaul, K. A., & Roder, D. M. (2001). Use of fake tanning lotions in the South Australian population. Medical Journal of Australia, 174(2), 75-78.
DOI Scopus27 WoS21 Europe PMC15
1991 Litjens, T., Morris, C. P., Gibson, G. J., Beckmann, K. R., & Hopwood, J. J. (1991). Human N-acetylgalactosamine-4-sulphatase: Protein maturation and isolation of genomic clones. Biochemistry International, 24(2), 209-215.
Scopus15 WoS14 Europe PMC10
1989 Occhiodoro, T., Beckmann, K. R., Morris, C. P., & Hopwood, J. J. (1989). Human α-L-fucosidase: Complete coding sequence form cDNA clones. Biochemical and Biophysical Research Communications, 164(1), 439-445.
DOI Scopus43 WoS43 Europe PMC36
1989 Litjens, T., Baker, E. G., Beckmann, K. R., Morris, C. P., Hopwood, J. J., & Callen, D. F. (1989). Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase. Human Genetics, 82(1), 67-68.
DOI Scopus63 WoS52 Europe PMC39

Year Citation
2024 Irenaeus, S., Garmo, H., Gedeborg, R., Robinson, D., Stattin, P., & Beckmann, K. (2024). Patterns of treatment in men with intermediate-, high-, and very high-risk prostate cancer according to their modelled life expectancy. In EUROPEAN UROLOGY Vol. 85 (pp. S1265-S1266). ELSEVIER.
2024 Tiruye, T. Y., Hiwase, M., Khalid, A., Li, M., Catterwell, R., Roder, D., & Beckmann, K. (2024). Medication and service use for mental illness in men diagnosed with prostate cancer: evidence from state-wide linked data. In BJU International Vol. 133 (pp. 79-80). UK: Wiley-Blackwell Publishing.
2024 Tiruye, T. Y., David, R., O'Callaghan, M., FitzGerald, L. M., Higgs, B., Kahokehr, A. A., . . . Beckmann, K. (2024). Incidence of second primary malignancies after curative therapy for prostate cancer: a population-based cohort study. In BJU International Vol. 133 (pp. 78-79). UK: Wiley-Blackwell Publishing.
2024 Tiruye, T. Y., Ettridge, K., O'Callaghan, M., Jay, A., Higgs, B., Moretti, K., . . . Beckmann, K. (2024). Communicating clinical registry data to consumers. In BJU International Vol. 133 (pp. 78). UK: Wiley-Blackwell Publishing.
2024 Charlick, M., Beckmann, K., Tiruye, T., Ettridge, K., O'Callaghan, M., Sara, S., & Jay, A. (2024). Barriers and facilitators to help-seeking for sexual dysfunction after prostate cancer: A scoping review. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 20 (pp. 249). WILEY.
2023 Christodoulidou, M., Beckmann, K., Van Hemelrijck, M., Ramachandran, N., Mitra, A., Richards, T., & Muneer, A. (2023). Sarcopenia as a prognostic indicator for the management of patients with penile cancer: The development of a novel prognostic nomogram. In EUROPEAN UROLOGY Vol. 83 (pp. S901-S902). ELSEVIER.
2022 Bundred, J. R., Dodwell, D., Cuttress, R., Michael, S., Stuart, B., Holleczek, B., . . . Bundred, N. J. (2022). Margin involvement in invasive breast cancer leads to increased distant recurrence after breast conservation: Systematic review. In CANCER RESEARCH Vol. 82 (pp. 2 pages). TX, San Antonio: AMER ASSOC CANCER RESEARCH.
DOI
2022 Tiruye, T., O'Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., . . . Beckmann, K. (2022). Patient-reported functional outcome measures at baseline and 12 months post-treatment and their association with treatment choice for prostate cancer. In BJU INTERNATIONAL Vol. 129 (pp. 19). Gold Coast, AUSTRALIA: WILEY.
2020 Crawley, D., Beckmann, K., Ravindra, S., Josephs, D. H., Spicer, J. F., Montes, A., . . . Ghosh, S. (2020). Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38 (pp. 2 pages). ELECTR NETWORK: LIPPINCOTT WILLIAMS & WILKINS.
WoS1
2020 Beckmann, K., Bangma, C., Hellman, J., Olalla, A. S., Nieboer, D., Bjartell, A., . . . Roobol, M. (2020). COMPARISON OF DIFFERENT BIOPSY SCHEDULES AMONG MEN ON ACTIVE SURVEILLANCE: ANALYSIS OF THE GAP3 GLOBAL CONSORTIUM DATABASE. In JOURNAL OF UROLOGY Vol. 203 (pp. E1291). DC, Washington: LIPPINCOTT WILLIAMS & WILKINS.
WoS1
2019 Bott, R., Zylstra, J., Wilkinson, M., Knight, W., Baker, C., Kelly, M., . . . Davies, A. (2019). The current role of adjuvant therapy in patients following neoadjuvant chemotherapy and R0 resection for lower oesophageal and GOJ adenocarcinoma. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 81). ENGLAND, Liverpool: WILEY.
2019 Bott, R., Zylstra, J., Wilkinson, M., Knight, W., Baker, C., Kelly, M., . . . Davies, A. (2019). Adjuvant chemoradiotherapy is beneficial in margin positive patients following neoadjuvant chemotherapy and surgery for lower oesophageal and GOJ adenocarcinoma. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 14). ENGLAND, Liverpool: WILEY.
2019 Beckmann, K., Russell, B., Josephs, D., Garmo, H., Haggstrom, C., Holmberg, L., . . . Adolfsson, J. (2019). ASSOCIATION BETWEEN CHRONIC INFLAMMATORY DISEASES, ANTI-INFLAMMATORY MEDICATIONS AND RISK OF PROSTATE CANCER. In JOURNAL OF UROLOGY Vol. 201 (pp. E596-E597). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
2019 Tan, T. W., Beckmann, K., Thurairaja, R., Khan, M. S., & Nair, R. (2019). OUTCOMES OF SALVAGE CYSTECTOMY IN PATIENTS FOLLOWING PRIOR PELVIC IRRADIATION: COMPARING ROBOT-ASSISTED VERSUS OPEN CYSTECTOMY. In JOURNAL OF UROLOGY Vol. 201 (pp. E286). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
WoS1
2019 Beckmann, K., Kinsella, N., Olsen, H., Wallerstedt-Lantz, A., Nordstrom, T., Aly, M., . . . Van Hemelrijck, M. (2019). IS PSA 'SCREENING' BEHAVIOUR ASSOCIATED WITH UPTAKE OF ACTIVE SURVEILLANCE IN MEN WITH LOW RISK PROSTATE CANCER?. In JOURNAL OF UROLOGY Vol. 201 (pp. E704). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
2019 Beckmann, K., Garmo, H., Adolfsson, J., Bosco, C., Johansson, E., Robinson, D., . . . Van Hemelrijck, M. (2019). CHANGES IN COMORBIDITY AFTER TREATMENT WITH GONADOTROPHIN RELEASING AGONISTS VERSUS ANTI-ANDROGEN MONOTHERAPY IN MEN WITH ADVANCED NON-METASTATIC PROSTATE CANCER. In JOURNAL OF UROLOGY Vol. 201 (pp. E321). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
2019 Tan, T. W., Beckmann, K., Thurairaja, R., Khan, M. S., & Nair, R. (2019). CHALLENGING THE DOGMA: OUTCOMES FOLLOWING ROBOT-ASSISTED CYSTECTOMY IN PATIENTS WITH PREVIOUS PELVIC IRRADIATION. In JOURNAL OF UROLOGY Vol. 201 (pp. E358). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
2019 Tan, T. W., Beckmann, K., Thurairaja, R., Khan, M. S., & Nair, R. (2019). Challenging the Dogma: outcomes following robot-assisted cystectomy in patients with previous pelvic irradiation. In BJU INTERNATIONAL Vol. 123 (pp. 4). SINGAPORE, Singapore: WILEY.
2016 Beckmann, K., Vincent, A., O'Callaghan, M., Sampurno, F., Ruseckaite, R., Evans, S., . . . Moretti, K. (2016). Oncological outcomes in an Australian cohort according to the new International Society of Urological Pathology (ISUP-2014) prostate cancer grading categories. In BJU INTERNATIONAL Vol. 118 (pp. 16-17). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2015 Beckmann, K., O'Callaghan, M., Ruseckaite, R., Moretti, K., Evans, S., Millar, J., . . . Roder, D. (2015). The changing profile of prostate cancer in South Australia. In BJU INTERNATIONAL Vol. 116 (pp. 20-21). Cairns, AUSTRALIA: WILEY-BLACKWELL.

Year Citation
2025 Charlick, M., Tiruye, T., Ettridge, K., O'Callaghan, M., Sara, S., Jay, A., & Beckmann, K. (2025). Sexual wellbeing support for men with prostate cancer: challenges and areas of change. Poster session presented at the meeting of BJU International. UK: Wiley-Blackwell Publishing.
2023 Hiwase, M., Tiruye, T., Khalid, A., Li, M., Roder, D., Catterwell, R., & Beckmann, K. (2023). Quantifying the prevalence of mental health issues following prostate cancer diagnosis in South Australian men using linked state-wide registry data. Poster session presented at the meeting of Asia Pacific Journal of Clinical Oncology. UK: Wiley-Blackwell Publishing.
DOI
2023 Tiruye, T., O'Callaghan, M., Ettridge, K., Jay, A., Santoro, K., Moretti, K., & Beckmann, K. (2023). Why men on active surveillance for prostate cancer have declined sexual function?. Poster session presented at the meeting of BJU International. UK: Wiley Blackwell Publishing.
DOI
2022 Tiruye, T., O' Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., . . . Beckmann, K. (2022). Patient-reported functional outcome measures at baseline and 12 months of commencing prostate cancer treatment. Poster session presented at the meeting of BJU International. UK: Wiley Blackwell Publishing.
DOI
2014 Beckmann, K., Hiller, J., Lynch, J., Farshid, G., Houssami, N., & Roder, D. (2014). OVERDIAGNOSIS DUE TO MAMMOGRAPHY SCREENING PROGRAMS: EVIDENCE FROM SOUTH AUSTRALIA. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL.

Year Citation
2023 Jayasinghe, D., Momin, M. M., Beckmann, K., Hypponen, E., Benyamin, B., & Lee, H. (2023). GxE PRS: Genotype-environment interaction in polygenic risk score models for quantitative and binary traits.
DOI Europe PMC1
  • South Australian Aboriginal Cancer Cohort Study to Improve Cancer Management and Outcomes, NHMRC - Clinical Trials and Cohort Studies, 31/10/2025 - 30/10/2030

  • Trends in survival from chronic myeloid leukaemia in Australia, Central Adelaide Local Health Network Incorporated, 01/06/2022 - 31/12/2024

  • Who to treat, when to treat and how to treat prostate cancer: Generating evidence to guide prostate cancer treatment decisions, NHMRC - Early Career Fellowship, 01/03/2017 - 28/02/2022

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor - - Master Full Time Mr Mark Zeman
2024 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Ms Ola Taleb
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Dovini Jayasinghe
2023 Principal Supervisor - - Master Full Time Ms Alexandra Stokes
2022 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mrs Sindhrani Dars

Connect With Me

External Profiles

Other Links